Papillary Thyroid CancerSymptoms, Doctors, Treatments, Advances & More
Papillary Thyroid Cancer Overview
Learn About Papillary Thyroid Cancer
View Main Condition: Thyroid Cancer
Papillary carcinoma of the thyroid is the most common cancer of the thyroid gland. The thyroid gland is located in front of the lower neck.
Papillary carcinoma of the thyroid; Papillary thyroid cancer; Papillary thyroid carcinoma
About 85% of all thyroid cancers diagnosed in the United States are the papillary carcinoma type. It is more common in women than in men. It may occur in childhood, but is most often seen in adults between ages 20 and 60.
The cause of this cancer is not known. A genetic defect or family history of the disease may be a risk factor.
Radiation increases the risk for developing thyroid cancer. Exposure may occur from:
- High-dose external radiation treatments to the neck, especially during childhood, used to treat childhood cancer or some noncancerous childhood conditions
- Radiation exposure from nuclear plant disasters
Radiation given through a vein (through an IV) during medical tests and treatments does not increase the risk for developing thyroid cancer.
Thyroid cancer often begins as a small lump (nodule) in the thyroid gland.
While some small lumps may be cancer, most (90%) thyroid nodules are harmless and are not cancerous.
Most of the time, there are no other symptoms.
Thyroid cancer treatment may include:
- Surgery
- Radioactive iodine therapy
- Thyroid suppression therapy (thyroid hormone replacement therapy)
- External beam radiation therapy (EBRT)
Surgery is done to remove as much of the cancer as possible. The bigger the lump, the more of the thyroid gland must be removed. Often, the entire gland is taken out.
After the surgery, you may receive radioiodine therapy, which is often taken by mouth. This substance kills any remaining thyroid tissue. It also helps make medical images clearer, so doctors can see if there is any cancer left behind or if it comes back later.
Further management of your cancer will depend on many factors such as:
- Size of any tumor present
- Location of the tumor
- Growth rate of the tumor
- Symptoms you may have
- Your own preferences
If surgery is not an option, external radiation therapy can be useful.
After surgery or radioiodine therapy, you will need to take medicine called levothyroxine for the rest of your life. This replaces the hormone the thyroid would normally make.
Your provider will likely have you take a blood test every several months to check thyroid hormone levels. Other follow-up tests that may be done after treatment for thyroid cancer include:
- Ultrasound of the thyroid
- An imaging test called a radioactive iodine (I-131) uptake scan
- Repeat FNAB
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Robert Tuttle is an Endocrinologist in New York, New York. Dr. Tuttle is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Gastrostomy.
UT MD Anderson Cancer Center
Ramona Dadu is an Endocrinologist in Cary, North Carolina. Dr. Dadu is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Thyroidectomy.
University Of Pittsburgh Physicians - Endocrine Surgery
Linwah Yip, MD, FACS, is an associate professor in the Department of Surgery, Division of Endocrine Surgery at the University of Pittsburgh School of Medicine, chief of the Division of Breast and Endocrine Surgery, and program director for the University of Pittsburgh Endocrine Surgery Fellowship. She specializes in thyroid and parathyroid disease/cancers, adrenal tumors, and functional pancreatic tumors. She studies how molecular testing can optimize diagnosis and treatment for thyroid cancer patients and leads the UPMC VHL Alliance Comprehensive Clinical Care Center.Dr. Yip is board-certified in general surgery. She received her medical degree from the University of Chicago Pritzker School of Medicine, Chicago. Dr. Yip completed surgical residency training at Northwestern University in Chicago and the University of Florida Health Sciences Center in Jacksonville, Fla., and surgical oncology research and clinical fellowships at the University of Texas MD Anderson Cancer Center and UPMC. Dr. Yip is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. Her top areas of expertise are Thyroid Nodule, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.
You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.
The survival rate for papillary thyroid cancer is excellent. More than 90% of adults with this cancer survive at least 10 to 20 years. The prognosis is better for people who are younger than 40 and for those with smaller tumors.
The following factors may decrease the survival rate:
- Older than 55 years of age
- Cancer that has spread to distant parts of the body
- Cancer that has spread to soft tissue around the thyroid
- Large tumor
Complications include:
- Accidental removal of the parathyroid glands, which help regulate blood calcium levels
- Damage to the nerve that controls the vocal cords
- Spreading of cancer to lymph nodes (rare)
- Spreading of cancer to other sites (metastasis)
Contact your provider if you have a lump in your neck.
Summary: Similarly, the burden of central lymph node metastasis affects the individualized management of patients with T1N0M0 papillary thyroid carcinoma (PTC): lymph node metastasis is a contraindication to thermal ablation; low-burden lymph node metastasis is suitable for lobectomy; and high-burden lymph node metastasis recommends total thyroidectomy. However, conventional preoperative imaging examinatio...
Summary: Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Ot...
Published Date: March 31, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 09/24/2025.
NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines) website. Thyroid carcinoma, Version 2.2024 - March 12, 2024. www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed May 10, 2024.
National Cancer Institute website. Thyroid cancer treatment (PDQ) - health professional version. www.cancer.gov/cancertopics/pdq/treatment/thyroid/HealthProfessional. Updated May 9, 2025. Accessed September 24, 2025.
Pearce EN, Hollenberg AN. Thyroid. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 207.
Sipos JA, Haugen BR. Papillary thyroid cancer. In: Randolph GW, ed. Surgery of the thyroid and parathyroid glands. 3rd ed. Philadelphia, PA: Elsevier; 2021:chap. 19.
Thompson LDR. Malignant neoplasms of the thyroid gland. In: Thompson LDR, Bishop JA, eds. Head and Neck Pathology. 3rd ed. Philadelphia, PA: Elsevier; 2019:chap 25.
